The evolution of European HTA and access to innovative medicines

In this article, the authors comment on the evolution of health technology assessment in the EU. This commentary, from the Journal of Comparative Effectiveness Research, is free to access exclusively for The Evidence Base® members. In recent years, across the European Union (EU), there has been a trend toward consolidating national-level bodies to a single supranational or pan-national authority. The pharmaceutical industry is no exception, and one of the key areas of discussion has been the creation of a unified approach to health technology assessment (HTA) for medicines and medical devices. In this commentary, Kate Kolotourou, Petra Ermacora and Alexander Grosvenor...